Target volume definition and locoregional failure in non-small-cell lung cancer

Frontiers of Radiation Therapy and Oncology

Volumn 34, Issue , 2000, Pages 89-96

  Rübe, Christian ^a   Nestle, Ursula ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003623729     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (47)

1. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, Perez-Tamayo R, Rotman M: Long-term observations of the pattern of failure in patients with unresectable non-oat-cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 1987;59:1874-1881.
2. Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M: Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial. Lancet 1997;350:161-165.
3. Dosoretz DE, Galmarini D, Rubenstein JH, Katin MJ, Blitzer PH, Salenius SA, Dosani RA, Rashid M, Mestas G, Hanna SE: Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 1993;27:507-516.
4. Perez CA, Stanley K, Rubin P, Kramer S, Brady LW, Perez-Tamayo R, Brown GS, Concannon J, Rotman M, Seydel HG: A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung: Preliminary report by the Radiation Therapy Oncology Group. Cancer 1980;45:2744-2753.
5. Dillman RO, Seagren SL, Herndon J, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF, Green MR: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990;323:940-945.
6. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Ememi B, Curran WJ, Byhardt RW, Turrisi AT, Dar AR, Cox JD: Radiation therapy oncology group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995;87:198-205.
7. Schaake-Koning C. Radiotherapy in non-small cell lung cancer: Optimal doses and schedules. Lung Cancer 1995;12(suppl 1):S119-S123.
8. Jeremic B, Shibamoto Y, Acimovic L, Djuric L: Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small cell lung cancer. J Clin Oncol 1995;13:452-458.
9. Furuse K, Kubota K, Kawahara M, Kodama N, Ogawara M, Akira M, Nakajima S, Takada M, Kusunoki Y, Negoro S: Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small cell lung cancer. Southern Osaka lung cancer study group. J Clin Oncol 1995;13:869-875.
10. Saunders M, Dische S, Barrett A, Harvey A, Griffiths G, Parmar M (on behalf of the CHART steering committee): Continuous hyperfradionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: Mature data from the randomised multicentre trial. Radiother Oncol 1999;52:137-148.
11. Internal Commission on Radiation Units and Measurements (ICRU) Report 50: Prescribing, Recording, and Reporting Photon beam therapy, ICRU, Bethesda, 1993.
12. Emami B, Graham M: Lung; in Perez CA/Brady L: Principles and Practice of Radiation Oncology. Philadelphia, Lipincott/Raven, 1997.
13. Stewart JR, Fajardo L, Gillette S, Constine L: Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995;31:1205-1211.
14. McDonald S, Rubin P, Phillips T, Marks L: Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995;31:1187-1203.
15. Coia L, Myerson R, Tepper J: Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 1995;31:1213-1236.
16. Theuws JCM, Kwa SLS, Wagenaar AC, Boersma LJ, Damen EMF, Muller SH, Baas P, Lebesque JV: Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol 1998;48:33-43.
17. Marks LB, Munley MT, Spencer DP, Sherhouse GW, Bentel GC, Hoppenworth J, Chew M, Jasczak RJ, Coleman RE, Prosnitz LR: Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 1997;38:399-409.
18. McGibney C, Holmberg O, McLean B, Williams C, McCrea P, Econ M, Sutton P, Armstrong J: Dose escalation of CHART in non-small cell lung cancer: Is three dimensional conformal radiation therapy really necessary? Int J Radiat Oncol Biol Phys 1999;45:339-350.
19. Choi NC, Doucette JA: Improved survival of patients with unresectable non-small cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach. Cancer 1981;48:101-109.
20. Hazuka MB, Bunn PA: Controversies in the nonsurgical treatment of stage III non-small cell lung cancer. Am Rev Resp Dis 1992;145:967-977.
21. Martini N, Flehinger BJ: The role of surgery in N2 lung cancer. Surg Clin North Am 1987;67:1037-1049.
22. Naruke T, Suemasu K, Ishikawa S: Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-836.
23. Watanabe K, Shimizu J, Tsubota M, Iwa T: Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma. Chest 1990;97:1059-1065.
24. Bollen E, van Duin C, Theunissen P, v.t Hof-Grootenboer B, Blijham G: Mediastinal lymph node dissection in resected lung cancer: Morbidity and accuracy of staging. Ann Thorax Surg 1993;55:961-966.
25. Gaer JA, Goldstraw P: Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus. Cardiothorac Surg 1989;4:207-210.
26. Tisi GM, Friedman PJ, Peters M: Clinical staging of primary lung cancer. Am Rev Resp Dis 1983;127:344-347.
27. Bülzenbruck H, Bopp R, Drings P, Bauer E, Krysa S, Probst G, VanKaick G, Müller KM, VogtMoikopf I: New aspects in the staging of lung cancer. Cancer 1992;70:1102-1110.
28. DeLeyn P, Vansteenkiste J, Cuypers P, Deneffe G, van Raemdonck D, Coosemans W, Verschakelen J, Lerut T: Role of cervical mediastinoscopy in staging of non-small-cell lung cancer without enlarged mediastinal lymph nodes on CT-scan. Eur J Cardiothorac Surg 1997;12:706-712.
29. Harris K, Adams H, Lloyd D, Harvey D: The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings. Clin Radiol 1993;18(suppl 2):31.
30. Schirren J, Richter W, Schneider P, Vogt-Moykopf I: Grundlagen und Ergebnisse der systematischen Lymphknotendissektion beim operierten Bronchialkarzinom. Chirurg 1996;70:179-183.
31. Dales R, Stark R, Raman S: Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Resp Dis 1990;141:1096-1099.
32. Musset D, Grenier P, Carette M, Frija G, Hanny M: Primary lung cancer staging: Prospective comparative study on MR imaging with CT. Radiology 1986;160:607-611.
33. Glatzer G, Gross B, Aisen A, Quint L, Francis I, Orringer M: Imaging of pulmonary hilum: A prospective comparative study in patients with lung cancer. AJR 1985;145:245-248.
34. Vansteenkiste JF, Stroobants SG, DeLeyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL, Mortelmans LA: Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small-cell lung cancer: A prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest 1997;112:1480-1486.
35. Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN: Lymph node staging in non small cell lung cancer: Evaluation by 18F FDG positron emission tomography (PET). Thorax 1997;52:438-441.
36. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, Weder W: Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202:441-446.
37. 18F-fluoro-deoxyglucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 1998;19:167-177.
38. Munley MT, Marks LB, Scarfone MS, Sibley GS, Patz EF, Turkington TO, Jasczak RJ, Gilland DR, Anscher MS, Coleman RE: Multimodality nuclear medicine imaging in radiation treatment planning for lung cancer: Challenges and prospects. Int J Radiat Oncol Biol Phys 1996;36:188.
39. Debois M, Fossard A, Vansteenkiste J, DeWever W, Verschkalen J, Bogaerts J, Gatti G, Stroobants S, Duponz P, Huyskens D, Kutcher J, Vanuytsel L: Impact of PET scan in lung cancer radiotherapy planning (abstract). Radiother Oncol 1998;48(suppl 1):S13.
40. Nestle U, Walter K, Schmid S, Licht N, Nieder C, Motaref B, Hellwig D, Niewald M, Ukena D, Kirsch CM, Sybrecht GW, Schnabel K: 18-F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 1999;44:593-597.
41. Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR: Anatometabolic' tumour imaging: Fusion of FDG-PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993;34:1190-1197.
42. Ekberg L, Holmberg O, Wittgren L, Bjelkengren G, Landberg T: What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother Oncol 1998;48:71-77.
43. Bentel G, Marks L, Krishnamurty R: Impact of craddle immobilisation on setup reproducibility during external beam irradiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 1991;20:1183-1190.
44. Ezz A, Munro P, Porter AT, Battista J, Jaffray D, Fenster A: Daily monitoring and correction of radiation field placement using a video-based portal imaging system. Radiother Oncol 1994;31:161-168.
45. Bel A, VanHerk M, Barttelink H, Lebesque J: A verification procedure to improve patient set-up accuracy using portal images. Radiother Oncol 1993;29:253-260.
46. Huang D, Tercilla O, Lutz S, Silverman L, Schmidt-Ullrich R: A patient self-gated technique for radiotherapy to lung cancer. Int J Radiat Oncol Biol Phys 1996;36(suppl 1):349.
47. Armstrong JG: Target volume definition for three-dimensional conformal radiation therapy of lung cancer. Br J Radiol 1998;71:597-594.